Covalently immobilized protein gradients in three-dimensional porous scaffolds

Patent metadata

Field	Value
Publication number	US-9290579-B2
Application number	US-40737306-A
Country	US
Kind code	B2
Filing date	Apr 19, 2006
Priority date	Apr 20, 2005
Publication date	Mar 22, 2016
Grant date	Mar 22, 2016

Abstract

The invention provides a method for forming an immobilized agent gradient within a 3-dimensional porous scaffold. A 3-dimensional scaffold formed from a biocompatible material is provided. The surface of the scaffold and/or the agent is activated so as to allow binding of the agent to the scaffold. The activated scaffold is contacted with a solution containing the agent. Contact with the solution is maintained for a sufficient period of time to allow diffusion of the solution through a portion of the scaffold, thereby forming a desired gradient of the agent through the 3-dimensional scaffold.

First claim

The invention claimed is:

1. A method for forming at least one immobilized agent gradient within a 3-dimensional porous scaffold comprising:
(a) providing a 3-dimensional porous silk fibroin scaffold;
(b) contacting the scaffold with an aqueous solution containing an agent to allow dispersion of the solution through at least a portion of the scaffold to form a linear gradient of the agent; and
(c) forming a covalent link between the agent and at least the surface of pores of said scaffold, whereby a first gradient of covalently linked immobilized agent is formed in said 3-dimensional porous scaffold.

2. The method of claim 1 , wherein the immobilized agent is a protein.

3. The method of claim 2 , wherein the protein is an enzyme, a cytokine, a growth factor, a cell binding domain and/or other cell signaling factor.

4. The method of claim 1 , wherein the immobilized agent is a chemotactic agent.

5. The method of claim 1 , wherein said solution is dispersed through the scaffold by convection, diffusion or both.

6. The method of claim 1 , wherein the scaffold is a hydrogel.

7. The method of claim 1 , further comprising forming at least one additional agent gradient in the scaffold.

8. The method of claim 2 , wherein the protein is bone morphogenetic protein (BMP).

9. A method for forming an immobilized agent gradient within a 3-dimensional porous silk fibroin scaffold comprising:
placing a solution mixture comprising silk fibroin and a porogen in a 3-dimensional mold;
inducing β-sheet structure in the silk fibroin to obtain a 3-dimensional aqueous-insoluble silk fibroin scaffold;
removing the porogen to form pores within the scaffold:
contacting the scaffold with an aqueous solution containing an agent to allow dispersion of the solution through at least a portion of the scaffold to form a linear gradient of the agent; and
forming a covalent link between the agent and at least the surface of the pores of the scaffold, whereby a gradient of covalently linked immobilized agent is formed in the 3-dimensional porous scaffold.

10. A method for forming a cell gradient within a 3-dimensional porous scaffold comprising:
(a) providing a 3-dimensional porous silk fibroin scaffold;
(b) contacting the scaffold with an aqueous solution containing an agent to allow dispersion of the solution through at least a portion of the scaffold to form a linear gradient of the agent, wherein the agent is selected from the group consisting of a cytokine, a growth factor, a cell binding domain, a chemotactic agent, and a cell signaling factor; and
(c) forming a covalent link between the agent and at least the surface of pores of the scaffold, whereby a gradient of covalently linked immobilized agent is formed in the 3-dimensional porous scaffold; and
(d) contacting the 3-dimensional porous scaffold with cells that respond to said agent to form a cell gradient within the 3-dimensional porous scaffold.

11. The method of claim 10 , wherein said agent is BMP.

12. The method of claim 1 , wherein at least the surface of the pores of the scaffold is activated to allow covalent linking of the agent to the activated surface of the pores of the scaffold.

13. The method of claim 1 , wherein at least the agent is activated to allow covalent linking of the activated agent to at least the surface of the pores of the scaffold.

14. The method of claim 12 , wherein the at least the surface of the pores is activated using an activating agent that introduces to the surface at least one functional group selected from the group consisting of hydroxysuccinimide esters, nitro- or dinitrophenyl esters, tosylates, mesylates, triflates, disulfides, and any combinations thereof.

15. The method of claim 14 , wherein the activating agent is 1-Ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC).

16. The method of claim 13 , wherein the agent is activated using an activating agent that introduces to the agent at least one functional group selected from the group consisting of hydroxysuccinimide esters, nitro- or dinitrophenyl esters, tosylates, mesylates, triflates, disulfides, and any combinations thereof.

17. The method of claim 16 , wherein the activating agent is 1-Ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC).

18. The method of claim 7 , wherein the at least one additional agent gradient has a slope same as or different from the slope of the first gradient.

19. The method of claim 7 , wherein the at least one additional agent gradient has a direction same as or different from the direction of the first gradient.

20. A 3-dimensional porous scaffold comprising at least one agent covalently immobilized within a biocompatible material and forming at least one linear gradient therein.

21. The 3-dimensional scaffold of claim 20 , further comprising cells within the biocompatible material.

22. The 3-dimensional scaffold of claim 21 , wherein the cells form a gradient response in the biocompatible material.

23. The 3-dimensional scaffold of claim 20 , wherein said at least one gradient is adapted to guide cell development for tissue regeneration and repair.

24. The 3-dimensional scaffold of claim 23 , wherein tissue regeneration and repair includes bone and cartilage regeneration, nerve growth, and/or angiogenesis.

25. The 3-dimensional scaffold of claim 20 , further comprising a monomer or polymer within the biocompatible material.

26. The 3-dimensional scaffold of claim 25 , wherein the monomer or polymer forms a polymer gradient in the biocompatible material.

27. The 3-dimensional scaffold of claim 20 , wherein a first agent and a second agent are covalently immobilized within the biocompatible material such that the first agent forms a first concentration gradient in a direction opposite to a second concentration gradient formed by the second agent.

28. The 3-dimensional scaffold of claim 20 , wherein the biocompatible material is selected from the group consisting of silk, collagen, keratin, fibronectin, chitosan, hyaluronic acid and alginates.

29. The 3-dimensional scaffold of claim 20 , wherein the biocompatible material comprises polylactic acid, polyglycolic acid, or a combination thereof.

30. The 3-dimensional scaffold of claim 20 , wherein the biocompatible material comprises silk.

31. The 3-dimensional scaffold of claim 20 , wherein said at least one agent comprises a protein or peptide.

32. The 3-dimensional scaffold of claim 31 , wherein the protein or peptide comprises an enzyme, a cytokine, a growth factor, a cell binding domain and/or other cell signaling factor.

33. The 3-dimensional scaffold of claim 20 , wherein said at least one agent comprises an enzyme.

34. The 3-dimensional scaffold of claim 33 , wherein the enzyme is selected for use as a biosensor.

35. The 3-dimensional scaffold of claim 20 , wherein said at least one agent comprises a chemotactic agent.

36. The 3-dimensional scaffold of claim 20 , wherein said at least one agent comprises a nucleic acid.

37. The 3-dimensional scaffold of claim 20 , wherein the biocompatible material has a consistent pore density.

38. The 3-dimensional scaffold of claim 37 , wherein the biocompatible material has a porosity of about 90%.

Assignees

• Vepari Charu
• Kaplan David L
• Vunjak-Novakovic Gordana
• Tufts College
• Massachusetts Inst Technology

Inventors

• Vepari Charu
• Kaplan David L
• Vunjak-Novakovic Gordana

Classifications

• C07K17/02 Primary

  Peptides being immobilised on, or in, an organic carrier · CPC title

• C12N11/04

  entrapped within the carrier, e.g. gel or hollow fibres · CPC title

• C07K17/04 Primary

  entrapped within the carrier, e.g. gel, hollow fibre · CPC title

• C12N11/06

  attached to the carrier via a bridging agent · CPC title

• C12N11/02

  Enzymes or microbial cells immobilised on or in an organic carrier · CPC title